Anaphylaxis produced by oxaliplatin.
We are discussing two patients, with clinically compatible reactions, who display an immediate hypersensitive mechanism following the administration of oxaliplatin, confirmed by the performance of cutaneous tests.
González-Mahave
I
I
Allergy Unit, Hospital San Millán-San Pedro, Logroño, Spain. migmahave@hsm.seris.es
Lobera Iabairu
T
T
Blasco Sarramián
A
A
del Pozo Gil
M D
MD
Zorrilla
M
M
Vélez de Mendizábal
E
E
D000328:Adult; D000707:Anaphylaxis / Q000209:etiology*; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000276:immunology; D003110:Colonic Neoplasms / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D009944:Organoplatinum Compounds / Q000009:adverse effects* / Q000276:immunology; D000077150:Oxaliplatin
D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin